Severe asthma: Current management, targeted therapies and future directions—A roundtable report
2016 · Respirology · 61 citations
https://doi.org/10.1111/resp.12957
S
Steven Maltby
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
82
Papers
2.4K
Citations
28
h-index
43
i10-index
Steven Maltby is an academic researcher. The author has contributed to research in topics: Asthma and respiratory diseases & IL-33, ST2, and ILC Pathways & Immune Cell Function and Interaction. The author has an h-index of 28, co-authored 70 publications.
ORCID: 0000-0003-1240-5964Papers by this author
worksTargeted therapeutics for severe refractory asthma: monoclonal antibodies
2016 · Expert Review of Clinical Pharmacology · 32 citations
https://doi.org/10.1586/17512433.2016.1172208
Interferon-epsilon is a novel regulator of NK cell responses in the uterus
2024 · EMBO Molecular Medicine · 15 citations
https://doi.org/10.1038/s44321-023-00018-6
Implementation and sustainment of virtual reality stroke workflow training for physician trainees at comprehensive stroke centres: a quantitative and qualitative study
2024 · BMC Medical Education · 3 citations
https://doi.org/10.1186/s12909-024-06438-3
Adhesion molecules in experimental peanut allergy
2010 · Allergy Asthma and Clinical Immunology · 1 citations
https://doi.org/10.1186/1710-1492-6-s3-p10
IL-7Rα and L-selectin, but not CD103 or CD34, are required for murine peanut-induced anaphylaxis
2012 · Allergy Asthma and Clinical Immunology · 1 citations
https://doi.org/10.1186/1710-1492-8-15
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat